» Articles » PMID: 36738633

Community-, Network-, and Individual-level Predictors of Uptake of Medication for Opioid Use Disorder Among Young People Who Inject Drugs and Their Networks: A Multilevel Analysis

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2023 Feb 4
PMID 36738633
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Opioid use has been increasing at alarming rates over the past 15 years, yet uptake of medication for opioid use disorder (MOUD) remains low. Much of the research on individual characteristics predicting MOUD uptake is equivocal, and there is a dearth of research on setting-level and network-level characteristics that predict MOUD uptake. Towards a more holistic, multilevel understanding, we explore individual-level, network-level, and community-level characteristics associated with MOUD uptake.

Methods: Baseline data from a longitudinal study of young people who inject drugs and their injection and support network members living in Chicago (N = 165) was used to conduct cross-sectional multilevel logistic regression analyses to examine associations between MOUD uptake and a set of potential predictors at the individual-, network-, and community-levels that were chosen based on theoretical relevance or support from previous empirical studies.

Results: Stigma at both the individual and community levels was significantly associated with MOUD uptake (though in different directions). Greater individual-level stigma was associated with a higher likelihood of MOUD uptake, while having a more normatively stigmatizing community environment was associated with a lower likelihood of MOUD uptake. Using heroin and cocaine simultaneously and having a larger support network were associated with a greater likelihood of MOUD uptake.

Conclusions: The present study's holistic, multilevel approach identified three individual-level characteristics, one network-level characteristic, and one community-level characteristic associated with MOUD uptake. However, more research is needed examining multilevel predictors, to help with developing interventions addressing barriers to MOUD use at multiple levels of influence.

Citing Articles

A scoping review of social determinants of health's impact on substance use disorders over the life course.

Lin C, Cousins S, Zhu Y, Clingan S, Mooney L, Kan E J Subst Use Addict Treat. 2024; 166:209484.

PMID: 39153733 PMC: 11418584. DOI: 10.1016/j.josat.2024.209484.


Mobile service delivery in response to the opioid epidemic in Philadelphia.

Stewart R, Christian H, Cardamone N, Abrams C, Drob C, Mandell D Addict Sci Clin Pract. 2023; 18(1):71.

PMID: 38031174 PMC: 10687974. DOI: 10.1186/s13722-023-00427-5.

References
1.
Weisner C, Matzger H, Tam T, Schmidt L . Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2003; 63(6):673-82. DOI: 10.15288/jsa.2002.63.673. View

2.
Pinedo M, Burgos J, Zuniga M, Perez R, Macera C, Ojeda V . Deportation and mental health among migrants who inject drugs along the US-Mexico border. Glob Public Health. 2016; 13(2):211-226. PMC: 5191974. DOI: 10.1080/17441692.2016.1170183. View

3.
Falade-Nwulia O, Felsher M, Kidorf M, Tobin K, Yang C, Latkin C . The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs. J Subst Abuse Treat. 2021; 137:108713. PMC: 9086095. DOI: 10.1016/j.jsat.2021.108713. View

4.
Cicero T, Kuehn B . Driven by prescription drug abuse, heroin use increases among suburban and rural whites. JAMA. 2014; 312(2):118-9. DOI: 10.1001/jama.2014.7404. View

5.
Page K, Hahn J, Evans J, Shiboski S, Lum P, Delwart E . Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009; 200(8):1216-26. PMC: 2821203. DOI: 10.1086/605947. View